explore -WSS

explore

author：knowledge 2025-09-30 02:15:39 - browse：1982

The FDA building -- First Opinion coverage from STAT — Adobe

A panel of independent advisers to the Food and Drug Administration voted overwhelmingly against a polarizing potential treatment for ALS on Wednesday, concluding that the medicine’s messy supporting data did not meet the standard for approval.

After a day-long meeting that included impassioned testimony from ALS patients, the agency’s expert advisers voted 17-1 with one abstention that the case for NurOwn, a treatment from BrainStorm Cell Therapeutics, was based too heavily on convoluted clinical trial results and compelling but unreliable anecdotal evidence.

“Patients and families need hope, but providing false hope can be ethically problematic,” said panelist Lisa Lee, a bioethicist at Virginia Tech. “False hope is provided when the probability of a positive outcome is overestimated, and I think that seems to be the case here.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Pharma’s losing bet in New Jersey

WSS

Why we need mandatory labeling of GMO products

Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

AltruBio raises $225 million to develop ulcerative colitis drug

Guardant Health colon cancer test endorsed by FDA advisory panel

The Bio Revolution is changing business and society

Some medical students still think black patients feel less pain

focus

explore

leisure time

Duchenne breakthrough therapy leaves behind pioneering families

Brain MRIs reveal impact of 'toxic stress' on Black children

Hepatitis C has a cure — but many Americans still lack access to it

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

Sports medicine is finally prioritizing gender equality

BIO to announce reorganization, senior leaders expected to depart

The cancer drug shortage isn’t new — and neither are the solutions

Achieving telehealth equity for people with hearing loss

Dobbs anniversary: the lost opportunity of abortion as health care

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

hotspot

Class action alleges UnitedHealth concealed DOJ probe

Guardant Health colon cancer test endorsed by FDA advisory panel

Brain technologies pose threats that are all too real, experts warn

The Bio Revolution is changing business and society

New research sheds light on how often breast cancer is overdiagnosed

Lawsuit challenges CMS nursing home minimum staffing rule

hotspot

hotspot

hotspot

focus